Stocks and InvestingStocks and Investing
Thu, February 2, 2023
Wed, February 1, 2023

Rick Bienkowski Initiated (BEAM) at Buy and Held Target at $62 on, Feb 1st, 2023


Published on 2024-10-28 01:16:25 - WOPRAI, Rick Bienkowski
  Print publication without navigation


Rick Bienkowski of Cantor Fitzgerald, Initiated "Beam Therapeutics Inc." (BEAM) at Buy and Held Target at $62 on, Feb 1st, 2023.

Rick has made no other calls on BEAM in the last 4 months.



There are 4 other peers that have a rating on BEAM. Out of the 4 peers that are also analyzing BEAM, 1 agrees with Rick's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Richard Law of "Credit Suisse" Maintained at Hold with Decreased Target to $53 on, Tuesday, November 8th, 2022


These are the ratings of the 3 analyists that currently disagree with Rick


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $77 on, Monday, January 23rd, 2023
  • Kostas Biliouris of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $66 on, Tuesday, December 20th, 2022
  • Samantha Semenkow of "Citigroup" Initiated at Strong Buy and Held Target at $62 on, Tuesday, December 13th, 2022